No long-term benefits of supplementation with arabinogalactan on serum lipids and glucose

Rebecca Marett, Joanne L. Slavin

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

We conducted a 6-month randomized, double-blind, parallel trial in which subjects consumed their usual diet plus arabinogalactan, a functional fiber isolated from either larch or tamarack. Healthy human subjects (28 men, 26 women) ages 18 to 55 years old consumed 8.4 g/day larch arabinogalactan (n=18), tamarack arabinogalactan (n=19), or a placebo of rice starch (n=17). Serum cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein B, apolipoprotein A-I, glucose, and insulin were measured monthly. Three-day food records, body weight, blood pressure, and gastrointestinal symptom surveys were obtained monthly. Serum lipids seemed to decrease at month 2, but there were no statistically significant differences among diets for any measured endpoint. Arabinogalactan is a recognized soluble fiber and is currently being used in products because it is not viscous, is easily incorporated into foods and beverages, and is well accepted by consumers.

Original languageEnglish (US)
Pages (from-to)636-639
Number of pages4
JournalJournal of the American Dietetic Association
Volume104
Issue number4
DOIs
StatePublished - Apr 2004

Fingerprint

Dive into the research topics of 'No long-term benefits of supplementation with arabinogalactan on serum lipids and glucose'. Together they form a unique fingerprint.

Cite this